MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Profound Medical Corp. Operating Income 2011-2026 | PROF
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Profound Medical Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -41.3 M | -33.1 M | -28.7 M | -32.1 M | -30.3 M | -18.9 M | -14.9 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -14.9 M | -41.3 M | -28.5 M |
Quarterly Operating Income Profound Medical Corp.
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.02 M | -8.91 M | -13.8 M | -11.2 M | -28.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -8.02 M | -28.6 M | -14.1 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.64 | -8.85 % | $ 330 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 4.17 | 0.97 % | $ 156 M |  France |
 |
Apyx Medical Corporation
APYX
|
-6.45 M | $ 4.05 | -7.11 % | $ 166 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-26.1 M | - | - | $ 3.31 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 7.66 | 1.19 % | $ 1.15 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.3 | -3.77 % | $ 1.4 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 17.72 | -1.01 % | $ 416 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.54 | -4.97 % | $ 66.2 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.27 | -5.22 % | $ 51.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.5 | -8.16 % | $ 31.1 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 70.0 | -2.33 % | $ 3.82 B |  Britain |
 |
MiMedx Group
MDXG
|
63.9 M | $ 3.56 | 0.28 % | $ 526 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 11.07 | -3.4 % | $ 397 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.01 | - | $ 17.1 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.91 | 2.49 % | $ 38.1 M | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 12.01 | -2.28 % | $ 476 M |  Curacao |
 |
Electromed
ELMD
|
9.66 M | $ 35.68 | -2.25 % | $ 302 M | USA |
 |
Butterfly Network
BFLY
|
-86.4 M | $ 3.83 | -6.59 % | $ 811 M | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 147.46 | -0.82 % | $ 10.4 B | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.27 | -5.62 % | $ 6.3 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 76.64 | -0.74 % | $ 10.4 B | USA |
 |
Stryker Corporation
SYK
|
4.89 B | $ 306.76 | 0.41 % | $ 117 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 35.49 | -2.34 % | $ 1.1 B | USA |
 |
Tactile Systems Technology
TCMD
|
29.3 M | $ 22.74 | -1.3 % | $ 520 M | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 40.05 | -6.12 % | $ 1.18 B | USA |
 |
Tandem Diabetes Care
TNDM
|
8.29 M | $ 12.82 | -9.4 % | $ 872 M | USA |